AtheroTalk: Dagmar Kratky
Prof. Dagmar Kratky is often called the “queen of lipid hydrolases” — and in this episode of AtheroTalk, she shares her passion for this fascinating…
Prof. Dagmar Kratky is often called the “queen of lipid hydrolases” — and in this episode of AtheroTalk, she shares her passion for this fascinating…
What does it take to turn scientific evidence into healthcare policy that improves lives? In this AtheroTalk episode, we sit down with Prof. Zanfina Ademi,…
There is no excerpt because this is a protected post.
EAS warmly congratulates Professor Wiegman on his outstanding contribution to paediatric lipidology, particularly his pioneering work in familial hypercholesterolaemia and lifelong cardiovascular prevention. Read more
Familial hypercholesterolaemia (FH) is a common genetic disorder characterized by lifelong elevated low-density lipoprotein cholesterol (LDL-C) concentrations, which increase the risk of premature atherosclerotic cardiovascular…
Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death worldwide, responsible for one in three deaths globally. Despite major advances in lipid testing, preventive…
This episode of AtheroTalk features Prof. Raul Santos from Brazil, reflecting on his journey in cardiovascular medicine and his impact on the field of lipidology.…
What does it take to build a career at the intersection of clinical care, research, and global collaboration? In this episode of AtheroTalk, we speak…
Join us as we unite to increase awareness, promote education, and support efforts to improve health outcomes associated with HoFH. On the occasion of HoFH…
Should we do cascade screening for Lp(a)? by Dr Jaimini Cegla Dr Jaimini Cegla has a special interest in lipidology and cardiovascular risk and divides…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.